Lund, Sweden

Olof Ekdahl

This inventor holds 11 USPTO granted patents and 8 published patent applications, plus 2 CIPO patents and 10 EPO patents. Top assignees: Baxter Healthcare Sa, Baxter International Inc., Gambro Lundia Ab. Active years: 2004-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Olof Ekdahl. Retrieved from https://idiyas.com/inventor/olof-ekdahl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 11 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.1

ph-index = 3

Forward Citations = 86(Granted Patents)


Company Filing History:


Years Active: 2004-2026

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Mind of Olof Ekdahl

Introduction: Olof Ekdahl, a distinguished inventor hailing from Lund, Sweden, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Olof Ekdahl's recent patents showcase his expertise in developing cutting-edge solutions for various industries, ranging from software advancements to sustainable energy technologies.

Career Highlights: With a career spanning over two decades, Olof Ekdahl has consistently pushed the boundaries of innovation, holding key roles in research institutions and leading tech companies.

Collaborations: Throughout his career, Olof Ekdahl has collaborated with top-tier researchers, engineers, and industry experts, fostering a culture of creativity and excellence in all his projects.

Conclusion: Olof Ekdahl's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and shape the future of the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…